ArticleFrontiers in pharmacology2021

Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews.

Yun-Kyoung Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.